February 19-21 2019
30+ Expert Speakers ♦ 3 Days ♦ 2 Streams ♦ 3 Workshops ♦ 10+ Hours of Networking
Holly Soares
Head of Translational Neuroscience
AbbVie
Murali Gopalakrishnan
Senior Director, Global Head, Search & Evaluation Neuroscience
AbbVie
Thomas Westerling-Bui
Senior Scientist
Aiforia
Martin Tolar
Founder, President & Chief Executive Officer
Alzheon
Tina Schwabe
Head, Immuno-Neurology
Alector
Jonathan Brotchie
Co-founder & Chairman
Atuka
Viktoria Kheifets
Senior Director of Biology
Alkahest
Jere Meredith
Director, Neuroscience
Research
Amgen
Daniel Klamer
Vice President, Business Development & Scientific Strategy
Anavex
Mathias Schmidt
Chief Executive Officer
ArmaGen
Jesse Cedarbaum
Vice President, Neurology Early Clinical Development
Biogen
Spyros Papapetropoulos
Executive Vice President, Head of Research & Development& Chief Medical Officer
Cavion
Diane Stephenson
Executive Director, Critical Path for Parkinson's
Critical Path Institute
Barbara Tate
Venture Partner
Dementia Discovery Fund
Nadeem Sarwar
Founder & President
Eisai Center for Genetics Guided Dementia Discovery
Johan Luthman
Vice President, Neuroscience Clinical Development
Eisai
Lee Rubin
Professor
Harvard Stem Cell
Institute
Anthony Lang
Senior Scientist
Krembil Research
Institute
Darren Baker
Assistant Professor
Mayo Clinic
Cyrille Sur
Executive Director, Neuroscience Imaging Lead
Merck
Sean Smith
Executive Director, Neuroscience Research
Merck
Sophie Parmentier-Batteur
Director, Neuroscience Discovery
Merck
C. Anthony Altar
Founder
NeuroDrug Consulting
Diana Price
Senior Director, Neurosciences & In Vivo Pharmacology
Neuropore Therapies, Inc
Robert C. Switzer
Founder, President & Chief Scientific Officer
NeuroScience Associates
Fiona Elwood
Head, Neurodegeneration
Novartis
Robert Bell
Associate Research Fellow Rare Disease Research Unit
Pfizer
Jonathan Levenson
Vice President, Preclinical Research and Development
Proclara BioSciences
Lloyd Mitchell
Chief Executive Officer & Chief Scientific Officer
RetroTherapy
Jacob Hunter
Director
Roche Diagnostics International Ltd
Pablo Sardi
Director, Neuroscience Research & Development
Sanofi
Richard Ransohoff
Entrepreneur In Residence
Third Rock Ventures
Jean-Philippe Courade
Director, Research Project Leader Neurodegeneration
UCB Biopharma
Ying Mengr
Neurosurgery Resident
University of Toronto
Michele Vendruscolo
Professor, Centre for Misfolding Diseases
University of Cambridge
Tricia Thornton-Wells
Director of Clinical Biomarkers, Translational Medicine and Biomarkers
Vertex Pharmaceuticals
Chee Yeun Chung
Scientific Co-founder & Associate Director
Yumanity Therapeutics
Jeffrey Kordower
Professor of Neurological Sciences
Rush University Medical Center
Kenneth Marek
President & Senior Scientist
Institute for Neurodegenerative Disorders
Matthew Kennedy
Director, Department of Neuroscience
Merck
Andrew West
Professor
Duke Center for Neurodegeneration Research
